Endo International plc

Equities

ENDPQ

IE00BJ3V9050

Pharmaceuticals

Market Closed - OTC Markets 03:35:14 2024-03-27 pm EDT 5-day change 1st Jan Change
0.0004 USD +33.33% Intraday chart for Endo International plc 0.00% -20.00%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Health Care Down on Rate Bias -- Health Care Roundup DJ
News Highlights : Top Company News of the Day - Wednesday at 5 PM ET DJ
Drugmaker Endo receives US court approval for bankruptcy restructuring RE
Drugmaker Endo receives US court approval for bankruptcy restructuring, Bloomberg News reports RE
Fourth Amended Joint Reorganization Plan Filed by Endo International plc CI
North American Morning Briefing : Stock Futures -2- DJ
Health Care Flat After Trial Setbacks -- Health Care Roundup DJ
Endo International plc Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Endo International plc Reports Property, Plant and Equipment Impairment Charges for the Three Months Ended December 31, 2023 CI
Endo International plc Provides Earnings Guidance for the Year 2024 CI
Endo International plc Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Drugmaker Endo reaches $465 mln bankruptcy settlement with US RE
Third Amended Joint Reorganization Plan and Disclosure Statement Filed by Endo International plc CI
Motion for Exclusivity Period Extension Approved For Endo International plc CI
News Highlights : Top Energy News of the Day - Friday at 4 PM ET DJ
News Highlights : Top Energy News of the Day - Friday at 11 AM ET DJ
News Highlights : Top Energy News of the Day - Friday at 7 AM ET DJ
News Highlights : Top Energy News of the Day - Friday at 4 AM ET DJ
News Highlights : Top Energy News of the Day - Friday at 12 AM ET DJ
Combined Hearing for Disclosure Statement and Plan Approved for Endo International plc CI
News Highlights : Top Energy News of the Day - Thursday at 4 PM ET DJ
News Highlights : Top Energy News of the Day - Thursday at 11 AM ET DJ
News Highlights : Top Energy News of the Day - Thursday at 7 AM ET DJ
News Highlights : Top Energy News of the Day - Thursday at 4 AM ET DJ
PRESS DIGEST-Wall Street Journal - Jan 11 RE
Chart Endo International plc
More charts
Endo International plc is a specialty pharmaceutical company. The Company operates through four business segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals and International Pharmaceuticals. Its Branded Pharmaceuticals segment includes a variety of branded products in the areas of urology, orthopedics, endocrinology, medical aesthetics and bariatrics, among others. Its products include XIAFLEX, SUPPRELIN LA, NASCOBAL Nasal Spray, AVEED, QWO, PERCOCET, TESTOPEL, EDEX and LIDODERM, among others. Its Sterile Injectables segment consists of branded sterile injectable products such as VASOSTRICT, ADRENALIN and APLISOL, among others, and certain generic sterile injectable products, including ertapenem for injection and ephedrine sulfate injection, among others. Its Generic Pharmaceuticals segment consists of a product portfolio including solid oral extended-release, solid oral immediate-release, liquids, semi-solids, patches, powders, ophthalmics and sprays.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Quarterly revenue - Rate of surprise

  1. Stock
  2. Equities
  3. Stock Endo International plc - OTC Markets
  4. News Endo International plc
  5. Endo International Unit Agrees to Commercialize Taiwan Liposome's Osteoarthritis Knee Pain Therapy Candidate